Mirae Asset Global ETFs Holdings’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$514K Sell
45,005
-4,799
-10% -$54.8K ﹤0.01% 1808
2025
Q1
$593K Buy
49,804
+5,286
+12% +$62.9K ﹤0.01% 1775
2024
Q4
$838K Buy
44,518
+5,899
+15% +$111K ﹤0.01% 1641
2024
Q3
$870K Buy
38,619
+9,044
+31% +$204K ﹤0.01% 1619
2024
Q2
$617K Buy
+29,575
New +$617K ﹤0.01% 1720